NCT01074411 - Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 5, 2010

Primary Completion Date

April 4, 2014

Study Completion Date

January 27, 2018

Conditions

Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous AdenocarcinomaFallopian Tube Transitional Cell CarcinomaOvarian Brenner TumorOvarian Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous AdenocarcinomaOvarian Mucinous CystadenocarcinomaOvarian Seromucinous CarcinomaOvarian Serous AdenocarcinomaOvarian Serous CystadenocarcinomaOvarian Transitional Cell CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaUndifferentiated Fallopian Tube CarcinomaUndifferentiated Ovarian Carcinoma

Interventions

DRUG

Bortezomib

Given IP

DRUG

Carboplatin

Given IP

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

Trial Locations (14)

22908

University of Virginia Cancer Center, Charlottesville

23298

Virginia Commonwealth University/Massey Cancer Center, Richmond

44106

Case Western Reserve University, Cleveland

44111

Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland

44124

Hillcrest Hospital Cancer Center, Mayfield Heights

44195

Cleveland Clinic Foundation, Cleveland

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

63110

Washington University School of Medicine, St Louis

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

06102

Hartford Hospital, Hartford

06050

The Hospital of Central Connecticut, New Britain

08103

Cooper Hospital University Medical Center, Camden

02905

Women and Infants Hospital, Providence